Table 6.

Prognostic Factors in Study DCLSG-ALL-7

Risk Factor No. of Patients (218 total) EFS P Value
5 yr (%)SE (%)
Sex  
 M  123  63.1  4.4  .40 
 F  95  68.1  4.8  
Age (yrs)  
 1-9  177 67.0  3.5  .25  
 ≥10  38  59.5  8.1 
WBC  
 <50,000  172  66.7  3.6  .16 
 ≥50,000  46  60.1  7.3  
Hb (mmol/L)  
 <5 118  68.4  4.3  .21  
 ≥5  99  61.2  5.0 
FAB (n = 216)  
 L-1  166  64.8  3.7  .40 
 L-2  47  71.7  6.8  
Immunophenotype (n = 197) 
 C-ALL  115  69.9  4.3  .11  
 Pre-B-ALL  48 60.3  7.1  
 T-ALL  34  57.8  8.6  
DNA index (n = 124)6-150 
 <1.16  88  70.4  4.9  .25 
 ≥1.16  36  80.6  6.6  
Ploidy (n = 109)6-150 
 Diploid  25  80.0  8.0  .16  
 Hyperdiploid 47-50 12  41.7  14.2  
 Hyperdiploid >50 chr  44  72.1 6.8  
 Pseudodiploid  28  64.1  9.1  
Chromosome structural anomalies (n = 124)  
 Absent  45  79.6 6.1  .019  
 Present  79  59.0  5.6  
Prednisone response (n = 210)  
 <1,000 blasts/μL  198  64.4 3.4  .86  
 ≥1,000 blasts/μL  12  74.4 12.7 
Risk Factor No. of Patients (218 total) EFS P Value
5 yr (%)SE (%)
Sex  
 M  123  63.1  4.4  .40 
 F  95  68.1  4.8  
Age (yrs)  
 1-9  177 67.0  3.5  .25  
 ≥10  38  59.5  8.1 
WBC  
 <50,000  172  66.7  3.6  .16 
 ≥50,000  46  60.1  7.3  
Hb (mmol/L)  
 <5 118  68.4  4.3  .21  
 ≥5  99  61.2  5.0 
FAB (n = 216)  
 L-1  166  64.8  3.7  .40 
 L-2  47  71.7  6.8  
Immunophenotype (n = 197) 
 C-ALL  115  69.9  4.3  .11  
 Pre-B-ALL  48 60.3  7.1  
 T-ALL  34  57.8  8.6  
DNA index (n = 124)6-150 
 <1.16  88  70.4  4.9  .25 
 ≥1.16  36  80.6  6.6  
Ploidy (n = 109)6-150 
 Diploid  25  80.0  8.0  .16  
 Hyperdiploid 47-50 12  41.7  14.2  
 Hyperdiploid >50 chr  44  72.1 6.8  
 Pseudodiploid  28  64.1  9.1  
Chromosome structural anomalies (n = 124)  
 Absent  45  79.6 6.1  .019  
 Present  79  59.0  5.6  
Prednisone response (n = 210)  
 <1,000 blasts/μL  198  64.4 3.4  .86  
 ≥1,000 blasts/μL  12  74.4 12.7 
F6-150

Only B-progenitor ALL categories.

Close Modal

or Create an Account

Close Modal
Close Modal